NANO-X IMAGING LTD Ordinary Shares (NNOX) is a publicly traded Healthcare sector company. As of October 28, 2026, NNOX trades at $0.32 with a market cap of $25.20M and a P/E ratio of 0.00. NNOX moved +0.72% today. Year to date, NNOX is -88.65%; over the trailing twelve months it is -91.74%. Its 52-week range spans $0.32 to $6.22. Rallies surfaces NNOX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nano-X reports $4.3M–$4.4M preliminary Q3 revenue and going-concern doubt: Nano-X Imaging’s preliminary third-quarter revenue rose year over year to $4.3 million to $4.4 million, with growth in AI and software solutions revenue. The company said cash and deposits expected as of September 30 would not cover one year, raising substantial doubt about its ability to continue as a going concern.
| Metric | Value |
|---|---|
| Price | $0.32 |
| Market Cap | $25.20M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.22 |
| 52-Week Low | $0.32 |
| Volume | 685.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
NNOX analyst coverage data. Average price target: $0.00.